Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases.

Chen Y, Cheng X, Song H, Wu AJ, Ku GY, Lee P, Slingerland M, Koyanagi K, Ke S, Qiu H, Shi W, Gao Y, Chen J; written on behalf of AME Radiation Oncology Collaborative Group.

J Thorac Dis. 2019 Apr;11(4):1536-1545. doi: 10.21037/jtd.2019.03.10.

2.

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.

Lyu J, Li T, Wang Q, Li F, Diao P, Liu L, Li C, Lang J.

Radiat Oncol. 2018 Nov 26;13(1):233. doi: 10.1186/s13014-018-1183-y.

3.
4.

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma.

Kim YI, Park JW, Kim BH, Woo SM, Kim TH, Koh YH, Lee WJ, Kim CM.

Radiat Oncol. 2013 Dec 21;8:292. doi: 10.1186/1748-717X-8-292.

5.

Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.

Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010401. doi: 10.1002/14651858.CD010401.pub2. Review.

6.

Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.

Song T, Du D, Zhang X, Fang M, Wu S.

Dis Esophagus. 2017 Sep 1;30(9):1-10. doi: 10.1093/dote/dox060.

PMID:
28859362
8.

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.

Choi Y, Oh DY, Kim K, Chie EK, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Ha SW, Bang YJ.

Cancer Res Treat. 2016 Jul;48(3):1045-55. doi: 10.4143/crt.2015.226. Epub 2015 Oct 16.

9.

Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.

Yoon DH, Cho Y, Kim SY, Nam SY, Choi SH, Roh JL, Lee SW, Song SY, Lee JH, Kim JS, Cho KJ, Kim SB.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):118-25. doi: 10.1016/j.ijrobp.2010.04.034. Epub 2010 Aug 2.

PMID:
20675065
10.

Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.

Bao Y, Liu S, Zhou Q, Cai P, Anfossi S, Li Q, Hu Y, Liu M, Fu J, Rong T, Li Q, Liu H.

Radiat Oncol. 2013 Oct 18;8:241. doi: 10.1186/1748-717X-8-241.

11.

Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.

Chen H, Zhou L, Yang Y, Yang L, Chen L.

Med Sci Monit. 2018 Jun 19;24:4183-4191. doi: 10.12659/MSM.910326.

12.

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.

Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T.

J Gynecol Oncol. 2017 Jan;28(1):e15. doi: 10.3802/jgo.2017.28.e15.

13.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
14.

Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea.

Kim YS, Kim BS, Jung SL, Lee YS, Kim MS, Sun DI, Yoo EJ, Mun SK, Yoon SC, Chung SM, Kim HK, Jo SH, Kang JH.

Cancer Res Treat. 2008 Dec;40(4):155-63. doi: 10.4143/crt.2008.40.4.155. Epub 2008 Dec 31.

15.

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma.

Ou D, Blanchard P, El Khoury C, De Felice F, Even C, Levy A, Nguyen F, Janot F, Gorphe P, Deutsch E, Temam S, Tao Y.

Oral Oncol. 2016 Nov;62:114-121. doi: 10.1016/j.oraloncology.2016.10.011. Epub 2016 Oct 22.

PMID:
27865364
16.

Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis.

Li Y, Tang LQ, Liu LT, Guo SS, Liang YJ, Sun XS, Tang QN, Bei JX, Tan J, Chen S, Ma J, Zhao C, Chen QY, Mai HQ.

Cancer Res Treat. 2018 Oct;50(4):1304-1315. doi: 10.4143/crt.2017.463. Epub 2018 Jan 8.

17.

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.

Huang PW, Lin CY, Hsieh CH, Hsu CL, Fan KH, Huang SF, Liao CT, Ng SK, Yen TC, Chang JT, Wang HM.

Biomed J. 2018 Apr;41(2):129-136. doi: 10.1016/j.bj.2018.04.003. Epub 2018 May 21.

18.

Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.

Korpics MC, Block AM, Martin B, Hentz C, Gaynor ER, Henry E, Harkenrider MM, Solanki AA.

Cancer. 2017 Sep 15;123(18):3524-3531. doi: 10.1002/cncr.30719. Epub 2017 Jun 5.

19.

Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.

Yao B, Tan B, Wang C, Song Q, Wang J, Guan S, Jia Y, Ma Y, Huang X, Sun Y, Cheng Y.

Ann Surg Oncol. 2016 Jul;23(7):2367-72. doi: 10.1245/s10434-016-5154-y. Epub 2016 Mar 1.

PMID:
26932711
20.

Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.

Wu CE, Lin YC, Hong JH, Chuang CK, Pang ST, Liaw CC.

Anticancer Res. 2013 Jun;33(6):2605-10.

PMID:
23749915

Supplemental Content

Support Center